Skip to main content

Table 3 Clinical and parasitological outcome variables

From: A randomized trial of the efficacy of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital, Cameroon

Outcome variables

Regimens

ARTES (n = 29)

QLD (n = 28)

QNLD3 (n = 30)

QNLD2 (n = 29)

Mean ± SD

Mean ± SD

p value

Mean ± SD

p value

Mean ± SD

p value

Fever clearance time (hours)

16.8 ± 8.1

24.9 ± 13.9

0.03

31.2 ± 14.3

<0.001

28.6 ± 14.0

<0.001

Coma recovery time (hours)

40.5 ± 36.1 (n = 2)

45.0 ± 21.2 (n = 2)

1.0

30.0 ± 15.6 (n = 3)

1.0

36.0 ± 0.0 (n = 2)

1.0

Time to sit unsupported (hours)

7.7 ± 5.4 (n = 13)

13.9 ± 1.8 (n = 7)

0.7

15.9 ± 2.3 (n = 6)

0.4

17.3 ± 1.9 (n = 9)

0.7

Time to eat (hours)

4.1 ± 3.8 (n = 14)

6.2 ± 2.7 (n = 12)

0.1

8.7 ± 2.5 (n = 8)

0.07

11.3 ± 2.3 (n = 9)

0.06

Time to exit from the protocol (hours)

28.6 ± 10.3

34.3 ± 12.8

0.01

37.4 ± 17.3

0.002

36.7 ± 12.4

0.01

PCT (hours)

19.2 ± 11.3

29.3 ± 18.0

0.03

36.4 ± 21.2

<0.001

29.5 ± 19.2

<0.001

PRR24 (%)

92.0 ± 10.4 (n = 9)

74.8 ± 24.0 (n = 18)

0.03

66.5 ± 22.0 (n = 22)

<0.001

71.7 ± 23.7 (n = 22)

0.03

  1. Significant p values are in italics
  2. PCT Parasite clearance time, PRR 24 Parasite reduction rate at H24